Global Healthcare ETF – Currency Hedged
- International shares
Invest in a portfolio of the world's leading healthcare companies
DRUG aims to track the performance of an index (before fees and expenses) that comprises the largest global healthcare companies (ex-Australia), hedged into Australian dollars.
Benefits of DRUG
Healthcare – a global growth opportunity
Ageing populations, rising living standards and ongoing medical advancements are expected to support increasing ongoing demand for healthcare products and services.
Simple access to global healthcare giants
Access a diversified portfolio of the world’s leading healthcare companies, such as Johnson & Johnson, Pfizer and Roche, in one trade.
Passive, index-tracking approach means no ‘active manager’ fees, making DRUG a cost-effective investment for those seeking exposure to the global healthcare sector.
There are risks associated with an investment in DRUG, including market risk, international investment risk, healthcare sector risk and concentration risk. Investment value can go up and down. An investment in the Fund should only be considered as a part of a broader portfolio, taking into account your particular circumstances, including your tolerance for risk. For more information on risks and other features of the Fund, please see the Product Disclosure Statement and Target Market Determination, both available on this website.
How to invest
- You can buy or sell units just like you’d buy or sell any share on the ASX.
- Fund requires no minimum investment.
|% Change (prev day)|
* Data is delayed by at least 20 minutes.
* As at 6 December 2023
|Net assets* ($A)||$153,206,421|
|Units outstanding* (#)||19,791,319|
|Management fee and cost** (p.a.)||0.57%|
|Distribution reinvestment plan (DRP)||Full or partial participation available|
|Issuer||Betashares Capital Ltd|
|Registry||Link Market Services|
* As at 6 December 2023**Certain additional costs apply. Please refer to PDS.
|Bloomberg code||DRUG AU|
|iNAV IRESS code||N/A|
|Market makers||Susquehanna Pacific|
|Index||Nasdaq Global ex-Australia Healthcare Hedged AUD Index|
|Bloomberg index ticker||NQXAUHHN Index|
Holdings & allocation
|UNITEDHEALTH GROUP INC||8.8%|
|ELI LILLY & CO||8.1%|
|JOHNSON & JOHNSON||6.2%|
|NOVO NORDISK A/S||5.4%|
|MERCK & CO INC||4.3%|
|ROCHE HOLDING AG||3.4%|
|THERMO FISHER SCIENTIFIC INC||3.3%|
* As at 7 December 2023. Excludes cash
|Health Care Equipment||13.7%|
|Managed Health Care||12.7%|
|Life Sciences Tools & Services||7.9%|
|Health Care Supplies||2.7%|
|Health Care Services||1.7%|
|Health Care Facilities||0.8%|
|Health Care Technology||0.5%|
* As of 31 October 2023
* As of 31 October 2023
Fund returns after fees (%)
|3 year p.a.||6.17%||6.59%|
|5 year p.a.||6.42%||6.72%|
|10 year p.a.||-||9.53%|
* As at 30 November 2023.
Past performance is not an indicator of future performance. Returns are calculated in Australian dollars using net asset value per unit at the start and end of the specified period and do not reflect brokerage or the bid ask spread that investors incur when buying and selling units on the ASX. Returns are after fund management costs, assume reinvestment of any distributions and do not take into account tax paid as an investor in the Fund. Returns for periods longer than one year are annualised. Current performance may be higher or lower than the performance shown.
Past performance is not indicative of future performance. Please refer to "Fund returns after fees" for additional information regarding performance/return information.
|12 mth distribution yield*||0.4%|
*As at 31 October 2023. Yield is calculated by summing the prior 12-month per unit distributions divided by the closing NAV per unit at the end of the relevant period. Yield will vary and may be lower at time of investment. Past performance is not indicative of future performance.
|Ex Date||Record Date||Payment Date||Distribution Unit ($)||Annual Distribution Return (%) (1)|
1 This is the annual distribution return to the end of the relevant distribution date. The distribution return reflects the contribution to total investment return made by the Fund's distributions. Distribution return is calculated as the total return less the growth return. Total return is calculated as the percentage change in a continuing investor's interest in the Fund assuming reinvestment of all distributions back into the Fund (and no other application or withdrawal), net of ongoing fees. Growth return is the Fund's return excluding distributions, net of ongoing fees. Past performance is not indicative of future performance.